We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Genmab AS | NASDAQ:GMAB | NASDAQ | Depository Receipt |
Bid Price | Offer Price | High Price | Low Price | Open Price | |
---|---|---|---|---|---|
26.28 | 29.01 | 28.76 | 28.09 | 28.75 |
Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
---|---|---|---|---|
23:46:29 | 10 | 28.10 | USD |
Date | Time | Source | Headline |
---|---|---|---|
09/1/2024 | 12:45 | DJN | Pfizer, Genmab Get Speedy FDA Review of Tivdak Full Approval |
25/9/2023 | 13:50 | DJN | AbbVie, Genmab Get Conditional Europe OK of Tepkinly Lymphoma Drug |
28/6/2023 | 00:48 | DJN | AbbVie, Genmab Need Further Follow Up on Trial for Follicular Lymphoma.. |
Genmab AS (GMAB) Charts1 Year Genmab AS Chart |
|
1 Month Genmab AS Chart |
Intraday Genmab AS Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions